Establishment Labs Holdings Inc Trading 6.48 percent Higher on Nov 20
ESTA Stock | USD 46.07 0.50 1.10% |
About 58% of Establishment Labs' investor base is looking to short. The analysis of overall sentiment of trading Establishment Labs Holdings stock suggests that many investors are alarmed at this time. The current market sentiment, together with Establishment Labs' historical and current headlines, can help investors time the market. In addition, many technical investors use Establishment Labs stock news signals to limit their universe of possible portfolio assets.
Establishment |
Shares of Establishment Labs Holdings Inc surged 6.48 percent in mid-day trading on Nov 20. The stock reached an intraday high of .98, before settling at
Read at gurufocus.com
Establishment Labs Investor Sentiment by Other News Outlets
Investor sentiment, mood or attitude towards Establishment Labs can have a significant impact on its stock price or the market as a whole. This sentiment can be positive or negative, and various factors, such as economic indicators, news events, or market trends, can influence it. When investor sentiment is positive, investors are more likely to buy stocks, increasing demand and increasing the stock price. Positive investor sentiment can be driven by good news about the company or the broader market, such as solid earnings reports or positive economic data.
Note that negative investor sentiment can cause investors to sell stocks, leading to a decrease in demand and a drop in the stock price. Negative sentiment can be driven by factors such as poor earnings reports, negative news about the company or industry, or broader economic concerns. It's important to note that investor sentiment is just one of many factors that can affect stock prices. Other factors, such as company performance, industry trends, and global economic conditions, can also play a significant role in determining the value of a stock.
Establishment Labs Fundamental Analysis
We analyze Establishment Labs' financials across various querterly and yearly statements, indicators and fundamental ratios. We help investors to determine the real value of Establishment Labs using virtually all public information available. We use both quantitative as well as qualitative analysis to arrive at the intrinsic value of Establishment Labs based on its fundamental data. In general, a quantitative approach, as applied to this company, focuses on analyzing financial statements comparatively, whereas a qaualitative method uses data that is important to a company's growth but cannot be measured and presented in a numerical way.
Price To Sales
Price To Sales Comparative Analysis
Establishment Labs is currently under evaluation in price to sales category among its peers. Price to Sales ratio is typically used for valuing equity relative to its own past performance as well as to performance of other companies or market indexes. In most cases, the lower the ratio, the better it is for investors. However, it is advisable for investors to exercise caution when looking at price-to-sales ratios across different industries.
Establishment Labs Potential Pair-trading
One of the popular trading techniques among algorithmic traders is to use market-neutral strategies where every trade hedges away some risk. Because there are two separate transactions required, even if one position performs unexpectedly, the other equity can make up some of the losses. Below are some of the equities that can be combined with Establishment Labs stock to make a market-neutral strategy. Peer analysis of Establishment Labs could also be used in its relative valuation, which is a method of valuing Establishment Labs by comparing valuation metrics with similar companies.
Peers
Establishment Labs Related Equities
APYX | Apyx Medical | 16.55 | ||||
LUNG | Pulmonx Corp | 2.54 | ||||
KIDS | Orthopediatrics Corp | 2.05 | ||||
ELMD | Electromed | 1.87 | ||||
SGHT | Sight Sciences | 1.79 | ||||
ITGR | Integer Holdings | 1.46 | ||||
GKOS | Glaukos Corp | 1.39 | ||||
INGN | Inogen | 0.31 | ||||
FNA | Paragon 28 | 0.10 | ||||
SRDX | SurModics | 0.10 | ||||
NPCE | Neuropace | 0.49 | ||||
CNMD | CONMED | 0.99 | ||||
TMCI | Treace Medical | 3.27 | ||||
LIVN | LivaNova PLC | 3.41 |
Complementary Tools for Establishment Stock analysis
When running Establishment Labs' price analysis, check to measure Establishment Labs' market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Establishment Labs is operating at the current time. Most of Establishment Labs' value examination focuses on studying past and present price action to predict the probability of Establishment Labs' future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Establishment Labs' price. Additionally, you may evaluate how the addition of Establishment Labs to your portfolios can decrease your overall portfolio volatility.
Options Analysis Analyze and evaluate options and option chains as a potential hedge for your portfolios | |
Economic Indicators Top statistical indicators that provide insights into how an economy is performing | |
Price Transformation Use Price Transformation models to analyze the depth of different equity instruments across global markets | |
Earnings Calls Check upcoming earnings announcements updated hourly across public exchanges | |
Technical Analysis Check basic technical indicators and analysis based on most latest market data | |
Headlines Timeline Stay connected to all market stories and filter out noise. Drill down to analyze hype elasticity | |
Premium Stories Follow Macroaxis premium stories from verified contributors across different equity types, categories and coverage scope | |
Piotroski F Score Get Piotroski F Score based on the binary analysis strategy of nine different fundamentals | |
Portfolio Manager State of the art Portfolio Manager to monitor and improve performance of your invested capital |